LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III

This adverse event was reported 845 times

These drugs are most commonly taken by patients reporting LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III:

# Drug Count
0 RANITIDINE 94
1 RANITIDINE HYDROCHLORIDE 38
2 ALBUTEROL SULFATE 17
3 TIOTROPIUM BROMIDE 16
4 ADALIMUMAB 15
5 PREDNISONE 12
6 METHOTREXATE SODIUM 11
7 ASPIRIN 10
8 ASPIRIN 325 MG 10
9 ASPIRIN 81 MG 10
See all common drugs associated with LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III

LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIGLITOL 2 0.0021
1 RANITIDINE HYDROCHLORIDE 38 0.0007
2 TIOTROPIUM BROMIDE AND OLODATEROL 3 0.0006
3 RANITIDINE 94 0.0005
4 AMOXICILLIN AND CLAVULANATE POTASSIUM 2 0.0004
5 SPARSENTAN 2 0.0003
6 GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE 2 0.0003
7 ERGOCALCIFEROL 8 0.0003
8 RANOLAZINE 2 0.0002
9 FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE 8 0.0002
See all drugs enriched for association with LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III